Most importantly, what are the triggers and regulators of the cell division cycle that drive the unsuccessful proliferation-attempt in neurons and how do these relate to ApoE, the strongest genetic risk factor for AD?
Such an increase in the epidermal thickness is supposed to occur in response to cell proliferation in attempt to regenerate the tissue, leading to a compensatory type of hyperplasia.
During AD progression, under continued stimuli of proliferation, neurons attempt to exit G0 and re-enter the cell cycle, as indicated by elevation of cell cycle markers and completion of DNA replication [ 5].
Consider the proliferation of attempts, in the UK and worldwide to establish free universities and autonomous educational networks and collectives.
The last 10 years have seen a proliferation of attempts to provide HCC patients with reliable staging and prognostic systems to overcome the inefficiency of the classical Child-Pugh [ 1], Okuda [ 2] and tumor-node-metastasis (TNM) [ 3] staging systems.
These studies revealed the presence of various types of intraductal proliferations and attempts were made to categorize these; the term 'atypical hyperplasia' or 'hyperplasia with atypia' was introduced and was used mainly to indicate the presence of proliferations of epithelial cells with cytonuclear atypia.
We use this system to examine whole genome transcription and alternate exon usage events that are regulated during lymphocyte proliferation in an attempt to evaluate the exon arrays.
The observed activated phenotype and increased cell turnover in Atg7 −/− CD8+ T cells are likely driven by homeostatic proliferation in an attempt to fill the depleted T cell niche.
These analysts maintain that the history of nuclear proliferation shows that attempting to thwart a nuclear program through an attack can have consequences opposite of those intended.
We have examined the effects of 1,25(on)2D3 on the differentiation of porcine MSC under culture conditions designed to promote proliferation in order to attempt to mimic the conditions in young, rapidly growing animals.
In non-diabetic mice, an antagonist causes low blood glucose levels, which lead to a sympathetic nervous system response and α-cell proliferation as the animals attempt to compensate for neuroglucopenia [19].
